secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001140361-23-035117
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Health Q2 preliminary revenue $4.5-4.7M, 16%-21% YoY growth, in line with guidance
--------------------------------------------------------------------------------

- Preliminary Q2 2023 revenue estimated at $4.5M to $4.7M, up 16%-21% vs Q2 2022.
- CEO Morgan Frank says results consistent with guidance provided in Q1 2023 earnings release.
- Production constraints mentioned as an ongoing challenge; full Q2 results expected mid-August.
- Preliminary figures subject to adjustment upon completion of quarter-end close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123035117/0001140361-23-035117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123035117/brhc20056056_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-035117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer